First four Stelara biosimilars launch in US; ‘white labeling ... - Healio
Mar 3, 2025 · Stelara (ustekinumab, Janssen) is an interleukin (IL)-12 and IL-23 inhibitor approved for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease and …
FDA Approves Imuldosa, Stelara Biosimilar For Treatment of …
Oct 15, 2024 · The FDA has approved Imuldosa (ustekinumab-srlf; Accord BioPharma), a biosimilar to Stelara (ustekinumab; Janssen Biotech), for the treatment of chronic inflammatory …
Ustekinumab Biosimilar Launches in the US - Pharmacy Times
Mar 20, 2025 · Ustekinumab-stba (Steqeyma; Celltrion), a biosimilar to ustekinumab (Stelara; Janssen Pharmaceuticals), has been launched in the US and is indicated for the treatment of …
FDA approves Amgen's interchangeable biosimilar of J&J's Stelara
Nov 1, 2023 · Amgen’s biosimilar approval has an added advantage as it has captured an interchangeable designation, which allows a pharmacist to freely substitute it for Stelara, …
FDA Approves Interchangeable Biosimilar for Multiple …
Today, the U.S. Food and Drug Administration approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory …
Welcome Wezlana: The First Stelara Biosimilar to Launch in the US
Jan 31, 2025 · January 1 marks the launch of the first biosimilar referencing Stelara (ustekinumab) in the US, ushering in a new class of lower-cost medicines for patients with …
FDA Approves Steqeyma: The Seventh Stelara Biosimilar
Dec 18, 2024 · The FDA has approved Steqeyma (ustekinumab-stba), Celltrion's biosimilar candidate referencing Stelara (ustekinumab), for the treatment of psoriatic conditions and …
FDA Approves Ustekinumab (STELARA) Biosimilar for Chronic …
Oct 14, 2024 · Ustekinumab-srlf (IMULDOSA) is FDA-approved as a biosimilar to STELARA for chronic inflammatory conditions, showing similar pharmacokinetics, efficacy, safety, and …
Updated: Two More Stelara Biosimilars Launch, Including One …
Feb 24, 2025 · There are four biosimilars of Stelara available to treat chronic autoimmune diseases — Wezlana, Selarsdi and now Pychiva and Yesintek. Sandoz and Biocon Biologics …
What to Know About Biosimilar for Stelara That Can Treat Psorasis
Nov 6, 2023 · The FDA has approved Wezlana, a biosimilar of Stelara, to treat a variety of rheumatic conditions, including psoriatic arthritis, Crohn's disease, and plaque psoriasis.
- Some results have been removed